+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Randomized, double-blind, placebo-controlled trial of basic fibroblast growth factor in the healing of gastroduodenal ulcers

Randomized, double-blind, placebo-controlled trial of basic fibroblast growth factor in the healing of gastroduodenal ulcers

Gastroenterology 110(4 Suppl. ): A267

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 033082022

Download citation: RISBibTeXText

Related references

Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 18(1): 64-69, 1995

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100(18): 1865-1871, 1999

Effects of basic fibroblast growth factor on the healing of partial-thickness donor sites. A prospective, randomized, double-blind trial. Wound Repair and Regeneration 2(2): 113-121, 1994

Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatology 66(7): 1820-1831, 2014

The effectiveness of hyperbaric oxygen therapy for healing chronic venous leg ulcers: A randomized, double-blind, placebo-controlled trial. Wound Repair and Regeneration 26(4): 324-331, 2018

Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. Helicobacter 12(5): 477-485, 2007

Results of a randomized, double-blind, placebo-controlled study of local perivascular basic fibroblast growth factor treatment in patients undergoing coronary artery bypass surgery. Journal of the American College of Cardiology 33(2 Suppl. A): 383A-384A, 1999

Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. Diabetes Research and Clinical Practice 142: 335-344, 2018

Double-blind, randomized, controlled clinical trial of the effects of diosmectite and basic fibroblast growth factor paste on the treatment of minor recurrent aphthous stomatitis. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 116(5): 570-575, 2013

Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers. American Journal of Surgery 173(3): 165-168, 1997

Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site. Wound Repair and Regeneration 15(6): 795-799, 2007

A double-blind, placebo-controlled, phase II study of basic fibroblast growth factor in the treatment of intermittent claudication. Circulation 102(18 Suppl.): II 373-II 374, 2000

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial. Bmc Nephrology 15: 71, 2014

Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study. Journal of Infectious Diseases 190(10): 1793-1796, 2004

A randomized, double blind placebo-controlled phase II trial of growth hormone and insulin-like growth factor I for AIDS wasting. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 56, 1994